Skip to main content
. 2014 Jul 24;177(3):712–719. doi: 10.1111/cei.12360

Figure 5.

Figure 5

Percentages of bronchoalveolar fluid (BALF) and peripheral blood CD4+ T cells expressing forkhead box protein 3 (FoxP3) before treatment, within 2–4 weeks and at 3 months (peripheral blood only) after the last treatment session.